Related Experiment Video
Updated: Oct 2, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
[Distal spleno-caval shunt in 66 patients with portal hypertension]
1Hepatobiliary Surgery Center, Southwestern Hospital, Third Military Medical University, Chongqing 400038.
Insights
Distal splenocaval shunt surgery effectively manages portal hypertension with a low rebleeding rate and good long-term survival. This procedure is a viable option for patients exhibiting hepatopetal portal flow.
Area of Science:
- Gastroenterology
- Surgical Gastroenterology
- Hepatology
Context:
- Portal hypertension is a serious complication of liver disease.
- Distal splenocaval shunt is a surgical option to manage portal hypertension.
- Evaluating long-term outcomes is crucial for surgical interventions.
Purpose:
- To assess the long-term efficacy and safety of distal splenocaval shunt.
- To report the operative experience and outcomes in a cohort of patients.
- To determine the suitability of this shunt for specific patient profiles.
Summary:
- A cohort of 66 portal hypertension patients underwent distal splenocaval shunt.
- The study reports a 7.58% operative mortality and a similar rate of recurrent bleeding.
- Five-year survival reached 70.45% with no cases of hepatic encephalopathy.
Impact:
- Distal splenocaval shunt demonstrates favorable long-term results for portal hypertension.
- The procedure is particularly suitable for patients with hepatopetal portal flow.
- This study contributes valuable data on the management of portal hypertension via shunting procedures.
Objective:
To evaluate the long-term results and operative experience of distal splenocaval shunt.
Method:
66 patients with portal hypertension were treated by distal spleno-caval shunt. Of these patients 57 were males and 9 females with a mean age of 39 years. All the patients were followed up.
Result:
The operative mortality rate was 7.58%. Only 5 patients experienced recurrent bleeding (7.58%). None of the patients had clinical hepatic encephalopathy. Five-year survival rate was 70.45%.
Conclusion:
Distal splenocaval shunt is suitable for portal hypertension patients with hepatopetal portal flow.
Related Concept Videos
Portal Hypertension
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction

